<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240605062020N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-07-25</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Examining the effect of exercise in people with panic symptoms</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of cognitive-behavioral therapy combined with physical exercises on anxiety symptoms, resiliency and quality of life in individual with panic symptoms</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-08-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/77322</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Factorial, Purpose: Supportive, Randomization description: Blocking is usually used in order to balance the number of samples assigned to each of the studied groups. This feature helps researchers to have the same number of samples assigned to each of the studied groups in cases where intermediate analyzes are needed during the sampling process.
The randomization method here is block randomization with individual units and the use of SAS software as a randomization tool.
Concealment of random assignment refers to the method used to perform a random sequence on the participants in the study, in a way that is done before assigning the individual to the group.
The assignment is not specific. Without hiding the random sequence, there is a possibility of revealing the random sequence, which eventually weakens the randomization process.
Here, to hide the allocation concealment of opaque sealed envelopes
Waxed random sequence (SNOSE) was used, Blinding description: In this study, the participants, the researcher, and the person in charge of data collection have been kept blind. In such a way that none of those who were mentioned know which persons and which group is the control and which is the experiment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Panic symptoms.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: It is the group that receives the intervention. The intervention includes 10 sessions of cognitive behavioral therapy two days a week and 15 sessions of aerobic exercise three days a week. Intervention 2: Control group: It is a group that performs the pre-test and post-test together with the intervention group. The intervention of group therapy and exercise is not done for the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The results of all things that can be published include: participant data file, study protocol, statistical analysis map, informed consent form, clinical study report, etc. can be shared.

When:
The access period starts 6 months after the results are published.

To whom:
To receive data and other study documents, researchers working in academic and scientific institutions or people working in the industry can apply.

Conditions:
The data and documentation of the study can be used for all research and treatment works.

Where to obtain:
Requesters can contact the e-mail address behrouzieh92@gmail.com to receive the desired documents or data.

How to obtain:
Applicants will receive the documents within a week after referring to the e-mail address behrouzieh92@gmail.com and stating the reason for using the documents, after reading and reviewing their application.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Behrouzieh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 14،  No. 13, 12 Qajarian Alley, 10 Hashemi Street, Hashemi Rafsanjani Highway</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9186333080</zip>
        <telephone>+98 51 3525 8576</telephone>
        <email>fbehrouzieh@icloud.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Behrouzieh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 14،  No. 13, 12 Qajarian Alley, 10 Hashemi Street, Hashemi Rafsanjani Highway</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9186333080</zip>
        <telephone>+98 51 3525 8576</telephone>
        <email>fbehrouzieh@icloud.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All people with panic disorder who are between 12 and 25 years old.</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>25 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>People who do not have symptoms of panic disorder.
People whose age is less than 12 years and more than 25 years.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: It is the group that receives the intervention. The intervention includes 10 sessions of cognitive behavioral therapy two days a week and 15 sessions of aerobic exercise three days a week.</i_keyword>
      <i_keyword>Control group: It is a group that performs the pre-test and post-test together with the intervention group. The intervention of group therapy and exercise is not done for the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety score in Beck Anxiety Questionnaire. Timepoint: Anxiety levels are measured at the beginning of the study (before the start of the intervention) and at the end of the study (end of the intervention). Method of measurement: Beck anxiety questionnaire.</prim_outcome>
      <prim_outcome>Flexibility score in acceptance and action questionnaire. Timepoint: Measuring the degree of flexibility is done at the beginning of the study (before the start of the intervention) and at the end of the study (end of the intervention). Method of measurement: Flexibility in the acceptance and action questionnaire.</prim_outcome>
      <prim_outcome>نمره میزان کیفیت زندگی در زمینه‌یابی سلامت 36 آیتمی (فرم کوتاه)36-item quality of life score in health research (short form). Timepoint: Quality of life is measured at the beginning of the study (before the start of the intervention) and at the end of the study (end of the intervention). Method of measurement: 36-item health background questionnaire (short form).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-06-05</approval_date>
        <contact_name>Research Ethics Committee of Islamic Azad University - Neishabur branch</contact_name>
        <contact_address>Unit 14،  No. 13, 12 Qajarian Alley, 10 Hashemi Street, Hashemi Rafsanjani Highway Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
